🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT05563662
Starting soon Observational

SURgical Registry of ENDocarditis EuRope

NCT05563662 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2023-09
Last updated
2023-05-10

Condition(s) studied

Infective EndocarditisCardiac SurgeryOutcomes

Investigational drug(s) / intervention(s)

Cardiac surgery

Cardiac surgery: Patients with infective endocarditis undergoing open heart surgery

Study summary

This is a prospective, multicentric, european registry of patients with infective endocarditis undergoing cardiac surgery. Patient demographics, clinical data and laboratory values will be collected, as well as treatment outcomes at day 30, day 90 and 1-5 years after the intervention.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients with infective endocarditis (according to DUKE criteria) undergoing cardiac surgery * Age ≥18 years * Written informed consent Exclusion Criteria: * Age \< 18 years * Missing declaration of consent * Current participation in another interventional trial

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Department of Cardiac Surgery, Hospital Nürnberg, Paracelsus Medical University Nuremberg Bavaria
University Hospital Essen, Department of Thoracic and Cardiovascular Surgery, West-German Heart and Vascular Center, University Duisburg-Essen Essen Germany

More University Hospital, Essen trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05563662 on ClinicalTrials.gov ↗ ← All trials in Germany